Home > Investor centre > Analyst coverage

Analyst coverage

Highlight: CEO, Dr Ros Wilson updates Scott Power, Senior Analyst, Morgans on the Company’s rapidly approaching key milestone — the Phase 2 clinical trial readout (August 2018).

Highlight: CEO, Dr Ros Wilson updates Scott Power, Senior Analyst, Morgans on the clinical trial, and details milestones for investors to focus on (December 2017).

Highlight: Newly appointed CEO, Dr Ros Wilson discusses her experience in the industry, her path to becoming CEO and the immediate challenges and opportunities for the Company (June 2017).

Highlight : Video interview between Scott Power (Morgans) and Executive Director, Dr. Christian Behrenbruch (December 2016).

Date Title Download
23rd Aug 2018 Morgans: Factor Therapeutics – Not Long To Wait Now
16th Jul 2018 Lodge Partners: Marc Sinatra, Research Report
24th Feb 2017 Edison : InvestorTrack Quarterly Update (Q1 2017)
13th Dec 2016 Bioshares Quarterly Update
28th Oct 2016 Edison Initiating Coverage: Factor Therapeutics - Healing Chronic Wounds
18th Oct 2016 Morgans: Factor Therapeutics - Short-Term Catalyst approaches
26th Apr 2016 Morgans: Tissue Therapies - Funding the future
4th Mar 2016 Bioshares special report: Sponsored by Taylor Collison